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0 Probing the role of homomeric 
and heteromeric receptor 
interactions in TGF-fl signaling 
using small molecule 
dimerizers. 
Brent R Stockwell and Stuart L 
Schreiber (1998). Cm. Biol. 8, 
761-770. 
Transforming growth factor p (TGF-P) 
arrests many cell types in the Gl phase 
of the cell cycle and up-regulates 
plasminogen activator inhibitor 1 
(PAI-1). The type I (TGF-PRI) and II 
(TGF-PRII) TGF-P receptors mediate 
these and other effects of TGF-P on 
target cells. TGF-P initially binds to 
TGF-PRII and subsequently TGF-PRI 
is recruited to form a heteromeric 
complex. TGF-PRI phosphorylates the 
downstream effecters SmadZ and 
Smad3, leading to their translocation 
into the nucleus. The authors explored 
the role of receptor oligomerization in 
TGF-P signaling by constructing fusion 
proteins containing receptor cytoplasmic 
tails linked to binding domains for 
small-molecule dimerizers. They 
showed that non-toxic, small molecules 
designed to oligomerize cytoplasmic 
tails of TGF-P receptors at the plasma 
membrane can activate TGF-fi 
signaling. TGF-P normally signals 
through two receptors that are both 
necessary for signaling in the 
small-molecule system described in this 
paper, but a dimerizer activates 
signaling through a single type of 
receptor that is sufficient to induce 
TGF-P signaling. The methods of 
activating TGF-j3 signaling described in 
this paper could be Extended to 
signaling pathways of other TGF-P 
superfamily members such as activin 
and the bone morphogenetic proteins. 
4 June 1998, Research Paper, Current 
Biology. 
0 The Kit receptor promotes cell 
survival via activation of PI 
3-kinase and subsequent Akt- 
mediated phosphorylation of 
Bad on Ser136. 
Peter Blume-Jensen, Ralf Janknecht 
and Tony Hunter (1998). Cum. Biol. 
8, 779-782. 
The c-&-encoded receptor protein 
tyrosine kinase for stem cell factor 
(Kit/SCF-R) is essential for the 
development of cells within the 
hematopoietic, melanogenic and 
gametogenic lineages. SCF stimulation 
induces activation of phosphatidyl- 
inositol (PI) 3-kinase, which is required 
for SCF-induced mitogenesis and cell 
survival, and for activation of the 
serine/threonine protein kinase Akt. 
Using Kit/SCF-R mutants, the authors 
found that, in response to SCF, Akt 
became activated and mediated 
phosphorylation of Bad, a pro-apoptotic 
molecule, in a PI-3-kinase-dependent 
manner. Phosphorylation of Bad was 
restricted to Serl12 and Ser136 in viva, 
but only the Akt phosphorylation site 
Ser136 was essential for SCF-promoted 
cell survival. Furthermore, Bad and Akt 
interacted and colocalized in intact cells. 
A Kit/SCF-R gain-of-function mutant 
that has increased mitogenic and PI 
3-kinase activation potential, due to the 
absence of the two protein kinase C 
negative feedback phosphorylation 
sites, enhanced both Akt activation and 
Bad phosphorylation and also resulted 
in increased cell survival. Such a 
mechanism could account for how 
deregulated PI 3-kinase activity and 
naturally occurring gain-of-function 
point mutants of Kit/SCF-R lead to 
cellular transformation and fatal 
malignancies in man. 
8 June 1998, Brief Communcation, 
Current Biology. 
0 Sequence-based design of a 
peptide probe for the APC 
tumor suppressor protein. 
Victoria Allen Sharma, Jennifer 
Logan, David S King, Ray White and 
Tom Albers (1998). Curr. Biol. 8, 
823-830. 
Finding new molecular probes targeted 
for proteins is limited by the absence of 
generally applicable recognition rules, 
because, although proteins form specific 
associations, predictive rules for protein 
pairing are generally unknown. Here, 
the authors describe amino-acid 
sequence patterns capable of mediating 
specific pairing of a widespread protein 
motif: the parallel, dimeric, a-helical 
coiled coil. The pairing rules were 
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tested by designing a 54-residue 
peptide (anti-APCp 1) that is predicted 
to dimerize preferentially with a coiled- 
coil sequence from the adenomatous 
polyposis coli (APC) tumor suppressor 
protein. Biochemical experiments 
showed that the anti-APC peptide 
preferentially forms a heterodimeric 
coiled coil with mutant and full-length 
APC proteins. The specificity of the 
designed peptide is sufficient to support 
several applications that commonly use 
antibodies. The observed specificity of 
anti-APCp 1 validates the pairing rules 
used as the basis for the probe design, 
and it suggests that residues in the core 
positions of coiled coils help impart 
pairing selectivity. 
18 June 1998, Research Paper, Current 
Biology. 
0 Site-selective dontrol of the 
reactivity pf surFace-exposed 
histidine residues in designed 
four-helix-bundle catalysts. 
Kerstin S Broo, Lars Brive, Richard 
S Sott and Lars Baltzer (1998). 
Fold. Des. 3, 303-312. 
The de novo design of proteins provides 
insight into protein folding and opens 
pathways towards the construction of 
new proteins. Designed and folded 
polypeptide catalysts have, so far, been 
reported that exhibit catalytic efficiencies 
Leu 1 
of more than three orders of magnitude 
over those of the corresponding 
uncatalysed reactions, but much remains 
to be understood about the optimisation 
of structure and function. The catalysis 
of an acyl-transfer reaction by a histidine- 
based polypeptide catalyst has been 
demonstrated previously with a catalytic 
efficiency of more than three orders of 
magnitude. Histidine, the most versatile 
amino acid in catalysis, has a pK, value 
that is close to 7 and it can therefore 
function as a nucleophilic catalyst, a 
general-acid catalyst and a general-base 
catalyst in aqueous solution around 
neutral pH. Histidine can also bind 
anions in its protonated form and cations 
in its unprotonated form. Thus, the 
tailoring of the reactivity of histidine can 
be expected to be of great interest in a 
number of catalysed reactions. Here, the 
authors systematically vary the 
environment of histidine residues in 
designed helix-loop-helix motifs to 
modulate histidine pK, values and 
reactivities. 25 helix-loop-helix motifs 
were designed in which surface-exposed 
histidine residues were flanked by 
neutral, negatively charged and 
positively charged groups and the 
histidine’s proximity to the hydrophobic 
core was varied. The 57 histidine pK, 
values were determined using lH NMR 
spectroscopy and found to be in the 
interval 5.2-7.2 with changes ranging 
from a decrease of 1.3 pK, units to an 
increase of 0.7 pK, units compared with 
the pK, for an unperturbed histidine 
residue. The principles described in this 
paper should be useful in the 
engineering of novel catalysts. 
30 June 1998, Research Paper, Folding 
& Design. 
0 Structural basis of the 
oligomerization of hepatitis 
delta antigen. 
Harmon J Zuccola, James E Rozzelle, 
Stanley M Lemon, Bruce W Erickson 
and James M Hogle (1998). 
Structure 6, 821-830. 
The hepatitis D virus (HDV) is a small 
satellite virus of hepatitis B virus 
(HBV). Coinfection with HBV and 
HDV causes severe liver disease in 
humans. The small 195 amino-acid form 
of the hepatitis delta antigen (HDAg) 
functions as a trans activator of HDV 
replication. A larger form of the protein 
containing a 19 amino-acid 
carboxy-terminal extension inhibits viral 
replication. Both of these functions are 
mediated, in part, by a stretch of amino 
acids predicted to form a coiled coil 
(residues 13-48) common to both forms. 
It is believed that HDAg forms dimers 
and higher ordered structures through 
this coiled-coil region. The high- 
resolution crystal structure of a synthetic 
peptide corresponding to residues 12-60 
of HDAg has been solved. The 
determination of the structure shows 
that HDAg dimerizes through an 
antiparallel coiled coil. Dimers associate 
further to form octamers through 
residues in the coiled-coil domain and 
residues carboxy-terminal to this region. 
The authors findings suggest that the 
structure of HDAg represents a 
previously unseen organization of a 
nucleocapsid protein and raise the 
possibility that the amino terminus could 
play a role in binding the viral RNA. 
15 July 1998, Research Paper, 
Structure. 
0 Bovine F,-ATPase covalently 
inhibited with 4-chloro-7- 
nitrobenzofurazan: the structure 
provides further support for a 
rotary catalytic mechanism. 
George L Orriss, Andrew GW 
Leslie, Kerstin Braig and John E 
Walker (1998). Structure 6, 
83 l-837. 
Fi-ATPase is the globular domain of 
F,F,-ATP synthase that catalyses the 
hydrolysis of ATP to ADP and 
phosphate. The crystal structure of 
bovine F,-ATPase has been determined 
previously, and is comprised of five 
different subunits in the stoichiometry 
c&y&; the three catalytic p subunits 
alternate with the three CI subunits 
around the centrally located single 
y subunit. To understand more about the 
catalytic mechanism, Fi-ATPase was 
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inhibited by reaction with 4-chloro-7- 
nitrobenzofurazan (NBD-Cl) and the 
structure of the inhibited complex 
(F,-NBD) determined using X-ray 
crystallography The F,-NBD inhibited 
state showed that NBD-Cl reacts with 
the phenolic oxygen of Tyr3 11 of the BE 
subunit, which contains no bound 
nucleotide. The inhibitor appears to 
prevent the BE subunit from being 
changed into a nucleotide-binding state, 
a change that would otherwise be 
brought about by the rotation of the y 
subunit in the active enzyme. The 
results presented here are consistent 
with a rotary catalytic mechanism of 
ATP synthesis and hydrolysis, which 
requires the sequential and concerted 
participation of all three catalytic sites. 
NBD-Cl inhibits the enzyme by 
preventing the modified subunit from 
adopting a conformation that is essential 
for catalysis to proceed. 
15 July 1998, Research Paper, 
Structure. 
0 Crystal structure of the C2 
domain from protein kinase C-6. 
H Pappa, J Murray-Rust, LV Dekker, 
PJ Parker and NQ McDonald (1998). 
Structure 6, 885-894. 
The protein kinase C (PKC) family of 
lipid-dependent serine/threonine kinases 
plays a central role in many intracellular 
eukaryotic signalling events. Members of 
the novel (6, E, 11, e) subclass of PKC 
isotypes lack the CaZ+ dependence of the 
conventional PKC isotypes and have an 
amino-terminal C2 domain. Biochemical 
data suggest that this domain serves to 
translocate novel PKC family members 
to the plasma membrane and might 
influence binding of PKC activators. In 
this paper, the determination of the 
crystal structure of PKC-6 C2 domain 
indicates an unusual variant of the C2 
fold. Structural elements unique to this 
I#.e 
C2 domain include a helix and a 
protruding B hairpin, which might 
contribute basic sequences to a 
membrane-interaction site. The 
amino-terminal sequence of Ca2+- 
independent novel PKCs defines a 
divergent example of a CZ structure 
similar to that of phospholipase C-6. The 
Caz+-independent regulation of novel 
PKCs is explained by major structural 
and sequence differences resulting in 
three nonfunctional Caa+-binding loops. 
The observed structural variation and 
position of a tyrosine-phosphorylation 
site suggest the existence of distinct 
subclasses of C&like domains which 
might have evolved distinct functional 
roles and mechanisms to interact with 
lipid membranes. 
15 July 1998, Research Paper, 
Structure. 
0 A novel strategy for inhibition of 
a-amylases: yellow meal worm 
a-amylase in complex with the 
Ragi bifunctional inhibitor at 
2.5 A resolution. 
Stefan Strobl, Klaus Maskos, Georg 
Wiegand, Robert Huber, 
F  Xavier Gomis-Ruth and Rudi 
Glockshuber (1998). Structure 6, 
911-921. 
a-Amylases catalyze the hydrolysis of 
a-D-(1,4)-glucan linkages in starch 
components, glycogen and various other 
related carbohydrates. There is a wide 
range of industrial and medical 
applications for these enzymes and their 
inhibitors. The Ragi bifunctional 
a-amylaseltrypsin inhibitor (RBI) is the 
prototype of the cereal inhibitor 
superfamily and is the only member of 
this family that inhibits both trypsin and 
a-amylases. The mode of inhibition of 
a-amylases by these inhibitors has so far 
been unknown. The authors have 
determined the crystal structure of 
yellow meal worm a-amylase (TVA) in 
complex with RBI, revealing a novel 
mechanism of inhibition of a-amylases 
from insect and mammalian sources by 
proteins from cereals. Because RBI 
inhibits two important digestive 
enzymes of animals, it constitutes an 
efficient plant defense protein and 
might be used to protect crop plants 
from predatory insects. 
15 July 1998, Research Paper, 
Structure. 
0 Cation binding to the integrin 
CD1 1 b I domain and activation 
model assessment. 
Eric T Baldwin, Ronald W  Sarver, 
Garold L Bryant Jr, Kimberly A  Curry, 
Michael B  Fairbanks, Barry C Finzel, 
Robert L Garlick, Robert L 
Heinrikson, Nancy C Horton, Laura- 
Lee C Kelley, Ana M  Mildner, Joseph 
B  Moon, John E  Mott, Veronica T 
Mutchler, Che-Shen C Tomich, Keith 
D Watenpaugh and Veronica H Wiley 
(1998). Structure 6, 923-935. 
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The integrin family of cell-surface 
receptors mediate cell adhesion through 
interactions with the extracellular matrix 
or other cell-surface receptors. The 
a chain of some integrin heterodimers 
includes an inserted ‘I domain’ of about 
200 amino acids that binds divalent metal 
ions and is essential for integrin function. 
It has been proposed that the I domain of 
the integrin CD1 lb adopts a unique 
‘active’ conformation when bound to its 
counter receptor and that the lack of 
adhesion in the presence of Caa+ ion 
reflected the stabilization of an ‘inactive’ 
I-domain conformation. The authors set 
out to independently determine the 
structure of the CD1 lb I domain and to 
evaluate the structural effects of divalent 
ion binding to this protein. The authors 
have determined the X-ray structure of 
a new crystal form of the CD1 1 b I 
domain in the absence of added metal 
ions using multiple isomorphous 
replacement. Metal ions were easily 
introduced into this crystal form 
allowing the assessment of the 
structural effects of divalent cation 
binding at the metal ion dependent 
adhesion site. The equilibrium binding 
constants for these ions were 
determined by titration calorimetry. 
The overall protein conformation and 
metal-ion coordination of the I domain 
is the same as that observed for all 
previously reported CD1 la I-domain 
structures and a CD1 ll3 I-domain 
complex with Mn2+. Addition of the 
cations Mgs+, Mna+ and Cds+ to the 
metal-free I domain does not induce 
conformational changes in the 
crystalline environment. Moreover, the 
authors find that Caz+ binds poorly to 
the I domain, which serves to explain 
its failure to support adhesion. These 
data show that the active conformation 
described previously is likely to be a 
construct artifact and that the currently 
available data do not support a dramatic 
structural transition for the I domain 
during counter-receptor binding. 
15 July 1998, Research Paper, 
Structure. 
